VERA compared with CLDX: revenue, margins and what each company keeps, and the suppliers and customers both name

VERAVera Therapeutics, Inc.

Mkt capRevenueRevenue

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VERAVera Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VERA 4

NVSNovartissupplier

—Amplyxunlistedsupplier

—Aresunlistedsupplier

—Stanfordunlistedsupplier

Shared 0

No shared counterparties.

Only CLDX 1

—Rockefeller Universityunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

VERAVera Therapeutics, Inc.

30.51· pre 31.91

Mkt cap$2.2BRevenue—Revenue—

CLDXCelldex Therapeutics, Inc.

30.10· pre 30.21

Pre-marketSep 2 '83

Mkt cap$2.4BRevenue$22,000Q2 FY26Revenue$7MFY24

Compare

Pre-marketSep 2 '83

VERAVera Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

30.51pre 31.91

Price

30.10pre 30.21

$2.2B

Mkt cap

$2.4B

—

Revenue

$22,000Q2 FY26

—

Revenue

$7MFY24

VERA30.51vsCLDX30.10Pre-marketSep 2 '83